What is the recommended treatment regimen for chronic sinusitis?

Treatment of Chronic Sinusitis

For chronic rhinosinusitis (CRS), initiate intranasal corticosteroids as first-line therapy, combined with high-volume saline irrigation, and reserve antibiotics only for acute infectious exacerbations with purulent discharge—not as routine maintenance therapy. 1, 2

Distinguishing Chronic from Acute Disease

• CRS is defined as symptoms lasting ≥12 weeks with objective evidence of inflammation (nasal endoscopy showing purulent mucus/edema/polyps, or CT imaging showing sinus inflammation) 1
• Do not treat CRS with the same antibiotic regimens used for acute bacterial sinusitis—the role of antibiotics in chronic disease is controversial and limited 1
• Confirm diagnosis objectively with anterior rhinoscopy, nasal endoscopy, or CT scan before committing to long-term treatment 1

First-Line Medical Management

Intranasal Corticosteroids (Primary Therapy)

• Use daily intranasal corticosteroids indefinitely as the cornerstone of CRS management 1, 2
• These improve overall symptom scores (standardized mean difference -0.46), reduce polyp size, and decrease polyp recurrence after surgery (relative risk 0.59) 2
• Continue for at least 3 months when symptoms resolve with treatment 1
• Multiple delivery methods available (sprays, rinses, implants); choice depends on disease distribution and patient preference 1

Saline Irrigation (Essential Adjunct)

• High-volume saline irrigation daily significantly improves symptom scores (standardized mean difference 1.42) 2
• This is evidence-based, low-cost, and has minimal adverse effects 1, 2

Antibiotic Use: When and How

Chronic Infectious Sinusitis

• Only prescribe antibiotics when purulent nasal discharge is present on examination (anterior, posterior, or both) 1
• For chronic infectious sinusitis requiring antibiotics, use longer duration therapy (minimum 3 weeks) with coverage for H. influenzae, anaerobes, and S. pneumoniae 1
• High-dose amoxicillin-clavulanate is preferred for anaerobic coverage 1
• Consider adding clindamycin or metronidazole for refractory cases suggesting anaerobic pathogens 1

Macrolide Therapy (Limited Role)

• 3-month course of macrolide antibiotics may improve quality of life in CRS without nasal polyps at 24 weeks post-treatment 2
• This represents anti-inflammatory rather than antimicrobial effect 2
• Do not use macrolides empirically as a third-party requirement for surgery or imaging 3

What NOT to Do

• Do not prescribe antibiotics for chronic non-infectious (hyperplastic) sinusitis—this represents inflammatory disease, not infection 1
• Avoid routine antibiotic prophylaxis; no published data support this practice 1

Systemic Corticosteroids

• Short courses (1-3 weeks) of oral corticosteroids reduce polyp size and may be considered for CRS with nasal polyps 1, 2
• Use when patients fail initial treatment, demonstrate nasal polyposis, or have marked mucosal edema 1
• For chronic hyperplastic sinusitis without infection, systemic corticosteroids are more appropriate than antibiotics 1

Adjunctive Therapies (Selective Use)

Antihistamines

• Only beneficial if underlying allergic rhinitis is present 1
• No role in non-allergic CRS 1
• May worsen symptoms by thickening secretions in non-atopic patients 1

Decongestants

• Topical decongestants (e.g., oxymetazoline) for maximum 5 days to avoid rhinitis medicamentosa 1
• Oral decongestants lack proven efficacy in CRS but may provide symptomatic relief 1

Leukotriene Antagonists

• Improve nasal symptoms in patients with nasal polyps (P < 0.01) 2
• Consider as adjunct therapy in polyp disease 2

Biologics for CRS with Nasal Polyps

• Dupilumab is FDA-approved for CRS with nasal polyps; other biologics (omalizumab, mepolizumab, benralizumab) show promise 4, 5
• Recommend against biologics when polyps are absent 3
• Educate patients about biologics when polyps are present as part of shared decision-making 1, 3
• These target type 2 inflammation and represent major advances for refractory disease 1, 5

Identifying Underlying Risk Factors

Evaluate and Treat Comorbidities

• Allergic rhinitis is present in many CRS patients; perform IgE testing to inhalant allergens 1
• Gastroesophageal reflux disease (GERD) treatment improves sinusitis symptoms in multiple studies 1
• Asthma frequently coexists; treating CRS improves asthma outcomes 1
• Consider immunodeficiency testing (quantitative immunoglobulins, functional antibody responses) in recurrent/refractory cases 1

Special Populations

• Aspirin-exacerbated respiratory disease (AERD): Consider aspirin desensitization therapy 1, 3
• Cystic fibrosis: Suspect in children with nasal polyps and Pseudomonas colonization 1

When Medical Therapy Fails

Indications for Specialist Referral

• Refractory to usual antibiotic treatment (failure after 21-28 days) 1
• Recurrent sinusitis (≥3 episodes per year) 1
• Significantly affects quality of life despite medical management 1
• Need to clarify allergic/immunologic basis 1
• Associated with unusual opportunistic infections 1

Surgical Considerations

• Functional endoscopic sinus surgery for medically resistant disease, especially localized ostiomeatal complex disease 1
• Surgery candidates benefit most when they have: polyps, bony erosion, eosinophilic mucin, or fungal balls 1
• Postoperative medical management is essential—surgery is not curative 1
• Patients should understand the expectation for long-term disease management following surgery 1

Common Pitfalls to Avoid

• Do not overdiagnose CRS based solely on self-reported symptoms without objective confirmation 1
• Do not use antibiotics as a prerequisite for surgery or imaging in the absence of infection 3
• Do not prescribe doxycycline for 3 weeks unless polyps are present (improves polyp size for 3 months post-treatment) 2
• Do not use cefixime or ceftibuten—these have poor activity against S. pneumoniae and penicillin-resistant strains 1
• Avoid premature classification as treatment failure before 7 days of therapy; symptom fluctuations in first 48-72 hours are common 1